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A procedure for the immunoassay of cohydrolase sphingolipid-I in mouse tissue is described. 
This cohydrolase (actually a mixture of at least four related proteins) stimulates or activates 
the &glucosidase which hydrolyzes ceramide glucoside, a widely occurring glycosphingolipid. 
The method involves extraction of cohydrolase from tissue homogenate with a salt-buffer 
solution, removal of proteins by adjustment to pH 6, further removal of proteins by heating, 
and removal of interfering materials with a small size exclusion column. Antibodies were raised 
to bovine cohydrolase in rabbits and purified with an alhnity column made from cohydrolase. 
The immunoassay involves binding of antibody by the cohydrolase sample (20-200 pg) in 
competition with cohydrolase that has been chemically linked to horseradish peroxidase. The 
mixture is treated with particle-linked second antibody and centrifuged; the pellet is then 
assayed thtorometrically for peroxidase content. Initial application of the method showed that 
cohydrolase was present in all mouse tissues studied and that its concentration paralleled that 
of glucocerebrosidase relatively closely. Changes with age (14 and 92 days) occurred in a similar 
fashion for the two substances. o 1984 Academic press, hc. 
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lase distribution in mouse tissues; glucocerebrosidase distribution in mouse tissues; changes 
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The term cohydrolase has been proposed 
as a generic term for the proteins which 
stimulate or augment the activity of various 
hydrolytic enzymes (I). The stimulator 
named cohydrolase SPH-I’ acts on glucosyl- 
ceramide glucosidase. It was discovered by 
Ho and O’Brien (2) in the spleen of a patient 
suffering from a genetic insufficiency of the 
enzyme activity (Gaucher disease). It occurs 
in normal spleen at a much lower level and 
evidently accumulates during the course of 
the disease, which also produces accumula- 
tion of the enzyme’s substrate, glucocerebro- 
side. The activator has been isolated from 
bovine (3) and human (1,4) spleen, and has 
’ Abbreviations used: SPH, sphingolipid, CHS-I, cohy- 
drolase SPH-I; PBS, 5 mM Na phosphate, pH 7, in 500 
mM NaCI; IgG, immunoglobulin G, BSA, bovine serum 
albumin; CNBr, cyanogen bromide. 
been found to consist of at least four heat- 
stable, electrophoretically separable proteins 
of very low molecular weight (1). Later work 
showed that cohydrolase SPH-I (CHS-I) also 
stimulates sphingomyelinase and galactosyl- 
ceramide galactosidase (5). 
The species-specificity of CHS-I seems to 
be low. Bovine CHS-I stimulates human and 
mouse glucosidases, and human CHS-I stim- 
ulates the bovine enzyme (3). 
Antibodies have been induced in rabbits, 
using the bovine CHS-I as antigen, and found 
to react to a similar degree with all four 
glucocerebroside cohydrolases of Gaucher 
spleen (1). Initial tests with a plastic-plate 
binding assay showed that the antibodies also 
reacted with mouse extracts, suggesting that 
it would be possible to devise an immunoas- 
say useful for physiological studies of cohy- 
drolase levels. 
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MATERIALS AND MET HODS 
Buffer A (5 I’nM Na phosphate, pH 7.0, in 
40 mM NaCl) was used for storing most 
samples. Crude glucocerebrosidase was iso- 
lated from bovine spleen (3) and assayed 
with methylumbelliferyl-fi-glucoside as sub- 
strate. Tritium-labeled substrate (N-stearoyl- 
[6-3H]glucosylsphingosine) was prepared syn- 
thetically (6). Hsd mice were from Harlan 
Sprague Dawley, Indianapolis, Indiana. 
Sample volumes at the microliter level 
were dispensed with a 5-, lo-, or 50-~1 mi- 
crosyringe. This allowed us to use relatively 
concentrated solutions and was important 
for preventing losses of CHS-I by adsorption 
onto containers (7). Vortexing for long peri- 
ods of time (5 min or more) was done with 
the Kraft Big Vortexer (Glas-Co1 Apparatus, 
Terre Haute, Ind.), a large vortexer which 
holds test tubes in a rack. We made a rack 
for 1.5-ml polypropylene centrifuge tubes by 
repeatedly pushing a tube into a rectangular 
block of foam plastic. 
Preparation of antibody. The IgG in the 
serum from one of the rabbits (1) was isolated 
with a column containing DEAE Affi-Gel 
Blue (Bio-Rad Laboratories, 153-7307). This 
is a beaded, crosslinked agarose containing 
diethylaminoethyl groups and covalently 
bound Cibacron Blue F3GA (8). The serum 
(6 ml) was dialyzed against 20 mM Tris-Cl-, 
pH 8.0, in 28 mM NaCl, and passed through 
the 1.8 X 18-cm packing previously equili- 
brated with the same buffer. The IgG in the 
effluent (same buffer) was assayed in plastic 
titer wells by binding bovine CHS-I to the 
plastic, binding the antibodies to the CHS-I, 
and binding peroxidase-linked anti-rabbit IgG 
to the rabbit IgG (1). The active proteins 
were found to elute as a single peak, moni- 
tored at 280 nm, between 36 and 210 ml. 
Half-maximal color in the peroxidase assay 
(0.26 A) was reached with about 275 ng of 
the protein in the pooled fractions. 
A second protein-containing peak was 
eluted with 20 mM Tris-Cl-, pH 8.0, con- 
taining 1.4 M NaCl. This peak yielded only 
the basal color in the titer-well assay at 
sample weights up to 1000 ng. The same 
negative reaction was obtained with the two 
peaks from control (nonimmune) serum from 
the same rabbit. 
The active fraction was concentrated by 
pressure ultrafiltration with an Amicon PM 10 
membrane and dialyzed against PBS. The 
yield was 28.6 mg of protein, based on the 
BSA standard in the copper-Folin reagent 
assay (9). 
The antibodies reacting with CHS-I were 
isolated from the IgG mixture with an affmity 
column (3.8 X 15 mm) made from 200 pg 
of bovine CHS-I and 100 mg of CNBr- 
activated Sepharose 4B (7) in PBS. Various 
amounts of IgG ( 1.8 to 4.55 mg) were passed 
through the packing in 0.5 to 2 ml of PBS. 
Nonspecific IgG was eluted with 6 ml of PBS 
and bound IgG was eluted with 3 ml of 1 M 
HOAc in 0.5 M NaCl (this solution had a 
pH of 2.6). A flow rate of 5 ml/h was used 
and 0.5-ml fractions were collected. The 
acidic fractions were promptly adjusted to 
pH 7 with 2 M Tris base, pooled after assay, 
and dialyzed against PBS during vacuum 
ultrafiltration (p-Micro-ProDiCon Model 10, 
Bio-Molecular Dynamics, Ore.). 
The alfmity column had a maximal binding 
capacity for the specific IgG of about 0.3 mg 
(8% of the crude IgG) and the recovery of 
protein in the two peaks was about 90% 
when a 3.7-mg sample was added to the 
column. In the titer-well assay for antibodies, 
the first protein fraction showed only the 
blank level of color in the peroxidase assay, 
while the specific fraction yielded half-maxi- 
mal color at about 75 ng of IgG. Comparing 
this value with the corresponding value ob- 
tained after the Cibacron Blue step (275 ng), 
we see an enrichment in specific IgG of 3.7- 
fold. Based on the yield from the affinity 
column, however, the enrichment appears to 
be 12.5-fold. 
Preparation of peroxidase-labeled CHS-I. 
Horseradish peroxidase (8 mg, Sigma Chem- 
ical Co., Type VI) was oxidized with periodate 
and linked to 2 mg of bovine CHS-I by 
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reduction with borohydride (10). The con- 
jugate, plus excess peroxidase, was separated 
from unreacted CHS-I with a column of 
Sephadex G-100 (1.6 X 80 cm) in 50 mM 
Tris-AcO-, pH 7.3. Elution was monitored 
by the ability of CHSI, even in the conjugated 
form, to stimulate glucosidase activity (3,ll). 
The first active fraction was pooled and 
mixed with human serum albumin (10 mg/ 
ml) and then stored in 0.2~ml portions at -20°C. 
Zmmunoassuyfor CZ-ZS--I. The method used 
(10) involves mixing an unknown or standard 
amount of CT-IS-1 with a standardized amount 
of CHS-I conjugated with peroxidase. To this 
is added purified IgG (too little to bind all 
the antigen). The antibody-antigen complex 
is precipitated with agarose-bound goat an- 
tibodies against rabbit IgG (Miles Laborato- 
ries), and the pellet is assayed for peroxidase 
content with 3-(phydroxyphenyl)propionic 
acid, a fluorogenic substrate ( 12). The reaction 
sequence is carried out in a l&ml polypro- 
pylene conical tube with attached cap, and 
all materials involved in immunological 
binding are diluted with 0.2 M Tris-AcG, 
pH 7.3, containing 0.05% human serum al- 
bumin and 0.05% Tween 20. To each tube 
is added (in the order shown) 20 ~1 each of 
CHS-I (O-200 pg), IgG (100 ng), and CHS- 
I-peroxidase (stock solution diluted 500-fold). 
The competitive binding proceeds 16 h at 
4”C, after which 0.2 ml of agarose-goat 
antibodies is added, enough to bind about 
6.6 pg of rabbit IgG. The tubes are vortexed 
10 min and then incubated for 3 h at 4°C. 
The suspension is centrifuged at 13,000g for 
3 min and the pellet is washed twice with 1 
ml of 50 mM Tris-acetate, pH 7.3; each time 
the pellet is vortexed 5 min. 
The enzyme content in the final pellet is 
assayed by adding 1 ml of 50 mM Tris- 
AcO-, pH 7.3, 50 ~1 of 3 mM hydrogen 
peroxide, and 50 ~1 of 30 IIIM hydroxyphen- 
ylpropionic acid and vortexing slowly for 1 
h. Then 50 ~1 each of 0.2 M KCN and 1 M 
NaOH is added and the tubes are vortexed 
5 min and then stored at 4°C for 16 h. After 
brief centrifugation, the fluorescence in the 
supematants is measured at 405 nm (excita- 
tion at 320 nm). 
The Tris buffers were prepared at room 
temperature. 
Assay for ghcosylceramide glucosidase ac- 
tivity. This was done with mouse tissue ho- 
mogenates prepared in 5 mM Na phosphate, 
pH 7, using 4 mg of liver or 6 mg of other 
tissues. The procedure (14) involves a l-h 
incubation of labeled lipid in Triton X- 100, 
taurocholate, and citrate-phosphate, pH 5.4, 
followed by solvent partitioning to isolate the 
radioactive glucose. The specific activities 
were independent of tissue weight (up to 6 
mg) and time (up to 1 h). 
RESULTS 
Immunoassay Sensitivity 
The relationship between weight of pure 
CHS-I and binding ratio exhibited excellent 
linearity and precision between 20 and 200 
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FlG. 1. Relationship between weight of bovine why- 
drohe SPH-I and ratio of observed enzyme activities 
(tluoreswnce readings). The value B is the peroxidase 
activity when whydrolase is added to the system; B. is 
the activity when whydmlase is absent. The points 
shown for each weight indicate the values observed on 
7 d&rent days, and the line connecting them is a 
composite of the seven standardization curves. 
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Extraction of CHS-I from Tissues TABLE 2 
Since CHS-I occurs in membranes as well 
as in cytosol of spleen (3), and since it binds 
to glucocerebrosidase (7), it was necessary to 
determine an appropriate extraction method. 
This was tested by homogenizing liver from 
120&y mice with a Brinkmann Polytron in 
10 vol of 5 mM phosphate, pH 7, or 0.1 M 
glycine chloride, pH 3. The homogenates 
were adjusted to pH 6 with 2 M HOAc or 
1% Na2HP04, kept at 4°C for 10 min, and 
centrifuged at 25,000g for 20 min. The clear, 
dark brown supematant was promptly trans- 
ferred to a screw-cap glass tube, heated 5 
min in boiling water, cooled in ice, and 
centrifuged at 10,OOOg for 15 min. This su- 
pematant was then analyzed by the immu- 
noassay method. 
EFFECT OF EXTRACTION pH ON YIELD 
OF COHYDROLASE 
Maximal CHS-I content was observed 
when the liver was extracted with pH 7 buffer 
containing 1 M NaCl (Table 1). At any NaCl 
concentration, the addition of Triton X- 100 
Volume of Amount of Concentration Relative 
sample cohydrolase of cohydrok yield 
PH (41) @!3) (ngfmg liver)” (W 
6.5 I 35135 3.84 
2 69170 3.02 85 
3 NM/106 3.88 
6.0 1 41141 4.53 
2 82/80 4.45 100 
3 128/126 4.65 
5.5 1 3013 I 3.35 
2 61162 3.38 75 
3 95194 3.46 
5.0 I 10/l 1 1.15 
2 19/19 1.05 23 
3 27127 0.99 
4.5 1 414 0.44 
2 lo/lo 0.55 11 
3 15/16 0.57 
Note. The pH of the liver homogenate was adjusted with acetic 
acid, centrifuged, heated to IOO°C, and centrifuged again. The 
supematant was purified by size exclusion and the active fraction 
analyzed by immunoassay. 
a Average of duplicate measurements. 
b Average of six measurements, relative to the maximum value. 
TABLE I 
EFFECTS OF DFFERENT EXTRACTING SOLUTIONS 
ON COHYDROLASE YIELD had no effect. The dissociating agent, urea, 




(A) 5 mM Phosphate, pH 7, 80 mM 
NaCl 3.90 
(B) A + Triton X-100, 1 mg/ml 3.96 
(C) Phosphate buffer + 440 mM NaCl 4.56 
(D) C + Triton 4.61 
(E) Phosphate buffer + 1.04 M NaCl 5.47 
(F) E + Triton 5.49 
(G) E + 8 M urea 2.01 
(H) G, but not heated at loO°C 2.32 
(I) 100 mM Glycine-Cl-, pH 3 1.83 
(J) I, but pH not adjusted to 6 0.71 
Note. At least two different tissue weights were assayed 
in duplicate and the results averaged. Minced, pooled 
livers were homogenized with the solutions described 
above, adjusted to pH 6, and centrifuged. The supema- 
tams were then heated in boiing water for 5 min, cooled, 
and centrifuged, and the supematant was assayed for 
CHS-I content. 
Since previous trials with bovine spleen 
had shown a strong dependence on extraction 
pH at low salt concentrations (3), this matter 
was studied in greater detail with mouse 
liver. Homogenization with phosphate at pH 
7 and the other steps listed above were used, 
but the pH after homogenization was adjusted 
to 4.0-6.5 instead of 6.0. In this experiment, 
the CHS-I extract was purified additionally, 
prior to assay, by passing 0.3 ml of the 
supematant through a 7 X 160-mm column 
of Sephadex G-75 (see next section). CHS-I 
was determined in l-, 2-, and 3-d aliquots 
of the CHS-I fraction (corresponding to 9.1, 
18.2, and 27.3 pg of liver). The results (Table 
2) show a remarkable sensitivity to extraction 
pH, 6.0 being best. The table also shows 
good proportionality to sample volume and 
good replication with duplicate samples. 
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Removal of Interfering Materials 
When various amounts of liver were as- 
sayed for CHS-I content using the heated 
extract, the apparent concentration was seen 
to decrease with tissue weights greater than 
14 pg. The maximal observed CHS-I concen- 
tration in the smallest aliquots was about 5.9 
ng/mg, but it decreased to 3.9 ng/mg with a 
27.3-pg sample of liver. Recovery tests with 
added pure bovine CHS-I gave values between 
60 and 83%. Accordingly, an additional pu- 
rification step was applied, as in the method 
used for CHS-I isolation (3). 
the CHS-I, and the last 4 ml was inactive. 
Good proportionality between liver weight 
and CHS-I content was found, with aliquots 
of column effluent equivalent to 4.55-36.4 
rg of liver (Table 3). To test for the presence 
of interfering materials, we added 80 pg of 
pure bovine CHSI to similar aliquots, prior 
to the size exclusion step, and found good 
recovery with samples corresponding to liver 
samples up to 27.3 pg (Table 3, right column). 
Table 3 also shows the severe interference 
with the assay due to materials in fractions 
A and C, which explains the need for the gel 
permeation step. 
A 7 X 160-mm (6.2 ml) column of Se- Another recovery test was made by adding 
phadex G-75, particle size (dry) 40-120 pm, bovine CHS-I to part of the initial liver 
was prepared in buffer A. A 0.3-ml sample homogenate, at the ratio of 4.5 1 ng/mg tissue, 
of heated liver extract, prepared as above at which almost doubled the amount of CHS-I 
pH 6, was passed through the column at 3 in the aliquots. The supplemented. and non- 
ml/h and eluted with more of the same supplemented samples were centrifuged, 
buffer. As expected from our knowledge of heated, and purified by gel permeation as 
bovine and human CHS-I behavior on such above, and then three different aliquots were 
a column (1,3), the first 2 ml contained no assayed from each active column fraction 
detectable CHS-I, the next 3 ml contained (Table 4). These samples also showed good 
TABLE 3 
LIVER CONTENT OF COHYDROLASE SPH-I AND RECOVEY OF ADDED COHYDROLASE 
Fraction 
Aliquot Amount Calculated Amount found Recovery of 
asSaYed found concentration after adding CHSI added CH!I-I 












































Note. Fractions A, B, and C are the first, middle, and final fractions (2, 3, and 4 ml, mspeetively) obtained from 
a Sephadex G-75 column, 7 X 160 mm. The column was loaded with extract from 27.3 mg of mouse liver and 
eluted at 3 ml/h. For the interference experiments, 80 pg of bovine CHSI was added before assay to duplicate 
aliquots from the column fractions. 
a Column effluent lirst diluted IO-fold with assay buffer. 
’ Column effluent first diluted 2-fold. 
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TABLE 4 
RECOVERY OF COHYDROLASE ADDED TO LIVER HOMOGENATE, 4.5 1 pgfa LIVER, PRIOR TO pH ADJUSTMENT, 
HEATING, AND SEPHADEX CHROMATOGRAPHY 
Aliquot Amount calculated Amount found Recovery of 
asSaY4 found concentration after adding CHSI added CHS-I 
(Pd (PS) (ng/mg liver) w 6) 
9.1 47 5.2 86 95 
9.1 48 5.3 87 95 
18.2 93 5.1 168 92 
18.2 92 5.1 168 93 
27.3 130 4.8 238 88 
27.3 130 4.8 238 88 
Note. Duplicate aliquots, three different amounts, were analyzed from each column. 
proportionality and recovery of added CHS- 
I, although some loss or interference could 
be seen at 27.3 gg of liver. However, the 
total CHS-I content from the supplemented 
sample (238 pg) was calculated by extrapo- 
lating from the high end of the calibration 
curve (Fig. I), so a low value can be expected. 
Specijicity of the Antibodies against CHS-I 
The possibility always exists that some 
tissue proteins can react nonspecifically with 
the IgG isolated from immunized rabbits. 
While our IgG was purified by two highly 
specific chromatographic steps, and the sam- 
ples were freed of heat-insolubilized protein, 
we nevertheless examined the heat-stable liver 
extract in greater detail. A taller Sephadex 
column (1.54 X 32 cm) was prepared and 
loaded with 3 ml of extract, as in the standard 
method. Fractions of 2 ml each were col- 
lected, at a flow rate of 15 ml/h, and moni- 
tored at 280 nm. As found with bovine 
spleen, the absorbance measurements showed 
an early peak, a low flat region, and a large 
late peak. Most of the CHS-I eluted in the 
intermediate low region. Immunoassay for 
CHS-I and evaluation of the glucocerebrosi- 
dase-stimulating activity showed single, some- 
what coincident peaks for both measurements 
(Fig. 2). 
The concentration of CHS-I in each col- 
umn fraction was calculated by the two assay 
methods, and the ratio of the two values, 
shown at the top of Fig. 2, was found to be 
close to 1 at all points along the peaks. The 
observed fluctuations are reasonable, consid- 











FIG. 2. Analysis of the cohydrolase in fractions obtained 
from a gel permeation column (Sephadex G-75j. One 
curve shows the results obtained in the immunoassay, 
and the other shows the results obtained in the cerebros- 
idase-stimulation assay. The curve at the top was derived 
by calculating the content of cohydrolase by both meth- 
ods, dividing one by the other. 
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Thus, by definition of CHS-I as a glucosidase 
stimulator, the immunoassay seems to mea- 
sure only CHS-I. It is possible, of course, 
that a high-molecular-weight pro-form of 
CHS-I exists in tissues, but this might be 
discarded by the heating or extraction step. 
Glew and Coffee recently reported that 
calmodulin from bovine brain has a weak 
stimulating activity with glucocerebrosidase 
from human liver (13). Our immunoassay 
method was applied to this protein (from 
bovine liver, Sigma Chemical Company, P- 
2277) and found to give a negative response 
with samples up to 1000 pg. Evidently cal- 
modulin and CHS-I are unrelated. 
Distribution of CHS-I and 
Glucocerebrosidase in Mouse Tissues 
If the primary role of CHS-I is to activate 
cerebroside glucosidase, one might expect the 
two to be distributed similarly among differ- 
ent organs. They have already been shown 
to have a similar distribution between spleen 
subcellular membrane fractions (3). In this 
first use of the immunoassay, we examined 
six tissues, pooled from ten 14day mice in 
two groups- of five each (Table 5). In this 
experiment, CHS-I was determined in two 
different aliquots derived from 9.1 and 27.3 
pg of tissue, each run in duplicate, the four 
values being averaged for use in Table 5. 
Liver was found to contain the highest con- 
centration of CHS-I and enzyme activity; 
heart and lung contained the lowest concen- 
trations. The maximum range was 3.6 to 1 
for glucosidase and 4.5 to 1 for CHS-I. The 
concentration of CHS-I in spleen was about 
half the values we found for bovine spleen 
(by isolation). 
The ratio of enzyme specific activity to 
CHS-I content (0.82 to 1.13) was strikingly 
similar for all organs. (There is no signikance 
to the actual numerical value, which is based 
on arbitrary units.) Comparison of the two 
values for each organ on successive lines 
shows good agreement, considering that two 
different groups of mice were analyzed. The 
glucosidase activities were similar to those 
reported for CF- 1 mice at age 16 (14). 
The same study with older mice (92 days) 
showed that both the enzyme activity and 
TABLE 5 
COMPARIXIN OF COHYDROLASE CONCENTRATION WITH GLUC~CEREEIRO~IDASE SPECIFIC Acrrvm 
IN TIZWES OF 14- AND %-DAY-OLD Mm 
CHSI (ng/mg tissue) 
14 days old 
92 days old 
Glucosidase (nmol/h/mg) 
14 days old 
92 days old 
Ratio” (enzyme/CH) 
14 days old 
92 days old 
Liver Spleen Brain Kidney Heart Lung 
3.64 1.76 1.57 1.23 0.81 0.81 
3.58 1.78 1.53 1.16 0.80 0.82 
4.48 1.83 1.36 1.24 0.55 0.63 
4.61 1.92 1.24 1.09 0.63 0.66 
3.02 1.76 1.38 1.37 0.85 0.81 
2.90 1.56 1.44 1.32 0.80 0.90 
3.83 1.96 1.17 1.14 0.52 0.68 
4.10 1.88 1.16 1.15 0.59 0.75 
0.82 0.94 0.91 1.13 1.02 1.05 
0.87 1.03 0.90 0.98 0.94 1.11 
Note. Each value shown is the average of duplicate assays from one column run; each line is derived from the 
pooled organs from a group of five mice. 
0 Bach ratio was calculated from all eight values for one organ. 
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CHS-I level increased with age in liver and 
spleen (the two organs that destroy blood 
cells) and decreased in brain, heart, and lung 
(Table 5). The two levels changed with age 
in very similar fashions so that the ratios 
remained the same. Liver was consistent in 
possessing the lowest enzyme/CHS-I ratio at 
both ages. 
DISCUSSION 
We attribute the high precision and linear- 
ity exhibited by the immunoassay procedure 
described here to the use of several features: 
(a) antibodies that have been “sorted” by the 
immunopurification step to have similar 
binding constants; (b) reduction in adsorptive 
losses by the use of relatively concentrated 
solutions, which are dispensed with positive 
displacement microliter syringes; (c) avoid- 
ance of variable, nonspecific wall-binding 
methods and nonspecific rabbit plasma pro- 
teins; and (d) a method of small-vessel mixing 
which is unusually thorough (a multiple-vial 
vortexer). 
Since CHS-I seems to activate two addi- 
tional sphingolipid hydrolases (5), it will be 
of interest to see if there is a similar parallel- 
ism for these enzymes. 
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